CA2873599A1 - Peptides induisant chez les poissons une reponse immunitaire contre les copepodes et/ou la formation d'un bouclier muqueux, vaccins, utilisations et methodes pour moduler la reponse immunitaire d'un poisson et/ou induire la production d'un bouclier muqueux - Google Patents

Peptides induisant chez les poissons une reponse immunitaire contre les copepodes et/ou la formation d'un bouclier muqueux, vaccins, utilisations et methodes pour moduler la reponse immunitaire d'un poisson et/ou induire la production d'un bouclier muqueux Download PDF

Info

Publication number: CA2873599A1
Authority: CA; Canada
Prior art keywords: seq; caligus; vaccine; fish; peptide
Prior art date: 2012-05-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2873599A

Other languages

English (en)

Inventor

Diego LATORRE

Matias Grosman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

TECNOVAX CHILE SA

Original Assignee

TECNOVAX CHILE SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-05-17

Filing date

2012-05-17

Publication date

2013-11-21

2012-05-17 Application filed by TECNOVAX CHILE SA filed Critical TECNOVAX CHILE SA

2013-11-21 Publication of CA2873599A1 publication Critical patent/CA2873599A1/fr

Status Abandoned legal-status Critical Current

Links

229960005486 vaccine Drugs 0.000 title claims description 333
108090000765 processed proteins & peptides Proteins 0.000 title claims description 112
241000251468 Actinopterygii Species 0.000 title claims description 102
102000004196 processed proteins & peptides Human genes 0.000 title claims description 65
241000239250 Copepoda Species 0.000 title claims description 35
238000000034 method Methods 0.000 title claims description 25
230000028993 immune response Effects 0.000 title claims description 21
238000011161 development Methods 0.000 title claims description 12
230000001939 inductive effect Effects 0.000 title claims description 5
235000019688 fish Nutrition 0.000 claims description 104
108090000623 proteins and genes Proteins 0.000 claims description 57
102000004169 proteins and genes Human genes 0.000 claims description 57
239000002671 adjuvant Substances 0.000 claims description 31
239000000203 mixture Substances 0.000 claims description 29
241000277275 Oncorhynchus mykiss Species 0.000 claims description 22
108060003552 hemocyanin Proteins 0.000 claims description 22
241000542855 Megathura crenulata Species 0.000 claims description 20
241000277338 Oncorhynchus kisutch Species 0.000 claims description 20
230000000890 antigenic effect Effects 0.000 claims description 20
241000237988 Patellidae Species 0.000 claims description 19
241000277263 Salmo Species 0.000 claims description 18
241000277288 Salmo trutta Species 0.000 claims description 17
239000002480 mineral oil Substances 0.000 claims description 17
235000010446 mineral oil Nutrition 0.000 claims description 17
239000000546 pharmaceutical excipient Substances 0.000 claims description 17
241001280377 Oncorhynchus tshawytscha Species 0.000 claims description 15
239000000839 emulsion Substances 0.000 claims description 15
241001247232 Caligidae Species 0.000 claims description 9
108010045069 keyhole-limpet hemocyanin Proteins 0.000 claims description 3
125000003275 alpha amino acid group Chemical group 0.000 claims 2
241001611011 Caligus Species 0.000 description 482
235000018102 proteins Nutrition 0.000 description 40
210000003097 mucus Anatomy 0.000 description 26
210000004027 cell Anatomy 0.000 description 25
241001611004 Caligus rogercresseyi Species 0.000 description 20
230000003053 immunization Effects 0.000 description 20
239000003921 oil Substances 0.000 description 20
244000045947 parasite Species 0.000 description 19
238000002255 vaccination Methods 0.000 description 19
206010061217 Infestation Diseases 0.000 description 18
241001247234 Lepeophtheirus salmonis Species 0.000 description 18
238000002649 immunization Methods 0.000 description 18
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
230000009467 reduction Effects 0.000 description 13
210000002966 serum Anatomy 0.000 description 13
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 12
230000003248 secreting effect Effects 0.000 description 12
241000277331 Salmonidae Species 0.000 description 11
241001247233 Lepeophtheirus Species 0.000 description 10
150000001413 amino acids Chemical group 0.000 description 9
238000004458 analytical method Methods 0.000 description 9
101710161198 Vitellogenin-1 Proteins 0.000 description 8
241000972773 Aulopiformes Species 0.000 description 7
241001674048 Phthiraptera Species 0.000 description 7
238000003556 assay Methods 0.000 description 7
230000000366 juvenile effect Effects 0.000 description 7
230000015572 biosynthetic process Effects 0.000 description 6
230000029087 digestion Effects 0.000 description 6
239000000499 gel Substances 0.000 description 6
230000003071 parasitic effect Effects 0.000 description 6
235000019515 salmon Nutrition 0.000 description 6
238000011282 treatment Methods 0.000 description 6
XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 5
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
101710161186 Vitellogenin-2 Proteins 0.000 description 5
108010090932 Vitellogenins Proteins 0.000 description 5
235000001014 amino acid Nutrition 0.000 description 5
210000000981 epithelium Anatomy 0.000 description 5
229920002401 polyacrylamide Polymers 0.000 description 5
238000002965 ELISA Methods 0.000 description 4
BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
230000002596 correlated effect Effects 0.000 description 4
235000018417 cysteine Nutrition 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
210000002615 epidermis Anatomy 0.000 description 4
238000009313 farming Methods 0.000 description 4
230000002163 immunogen Effects 0.000 description 4
230000000091 immunopotentiator Effects 0.000 description 4
230000001965 increasing effect Effects 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
238000004949 mass spectrometry Methods 0.000 description 4
229940035032 monophosphoryl lipid a Drugs 0.000 description 4
239000013535 sea water Substances 0.000 description 4
239000007790 solid phase Substances 0.000 description 4
239000000725 suspension Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
241000607479 Yersinia pestis Species 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
230000021615 conjugation Effects 0.000 description 3
230000001524 infective effect Effects 0.000 description 3
238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
238000005070 sampling Methods 0.000 description 3
210000003491 skin Anatomy 0.000 description 3
241000894007 species Species 0.000 description 3
238000003786 synthesis reaction Methods 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
241001522303 Acanthis Species 0.000 description 2
241000704622 Antennatus Species 0.000 description 2
241000571350 Caligus aesopus Species 0.000 description 2
241000571347 Caligus callaoensis Species 0.000 description 2
241001235711 Caligus centrodonti Species 0.000 description 2
241000420702 Caligus cheilodactyli Species 0.000 description 2
241000571348 Caligus chorinemi Species 0.000 description 2
241000712786 Caligus clemensi Species 0.000 description 2
241000571346 Caligus confusus Species 0.000 description 2
241001235719 Caligus curtus Species 0.000 description 2
241001382015 Caligus diaphanus Species 0.000 description 2
241001405819 Caligus elongatus Species 0.000 description 2
241000109841 Caligus fugu Species 0.000 description 2
241000571427 Caligus hoplognathi Species 0.000 description 2
241000571430 Caligus mutabilis Species 0.000 description 2
241001235717 Caligus pelamydis Species 0.000 description 2
241001155277 Caligus punctatus Species 0.000 description 2
241001382014 Caligus quadratus Species 0.000 description 2
241000571422 Caligus robustus Species 0.000 description 2
241000571424 Caligus sclerotinosus Species 0.000 description 2
241000571399 Caligus serratus Species 0.000 description 2
241000571400 Caligus tylosuri Species 0.000 description 2
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
108010078791 Carrier Proteins Proteins 0.000 description 2
241001436044 Chelifer Species 0.000 description 2
102000019034 Chemokines Human genes 0.000 description 2
108010012236 Chemokines Proteins 0.000 description 2
102000009016 Cholera Toxin Human genes 0.000 description 2
108010049048 Cholera Toxin Proteins 0.000 description 2
241000522241 Cordyla <angiosperm> Species 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
101710146739 Enterotoxin Proteins 0.000 description 2
229920001503 Glucan Polymers 0.000 description 2
241001401881 Longicaudus Species 0.000 description 2
241000781273 Longipedis Species 0.000 description 2
241000972747 Macrourus Species 0.000 description 2
241000737052 Naso hexacanthus Species 0.000 description 2
241000123077 Ocyurus Species 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
241000873862 Paracyclopina nana Species 0.000 description 2
241000606012 Pectinatus Species 0.000 description 2
241000882917 Pomacentrus Species 0.000 description 2
241001098657 Pterois Species 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
241000238680 Rhipicephalus microplus Species 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
241000306752 Salmoneus Species 0.000 description 2
241000269851 Sarda sarda Species 0.000 description 2
241001194796 Schistonyx Species 0.000 description 2
241001290310 Sciaenops Species 0.000 description 2
241001187507 Sicarius Species 0.000 description 2
241000045687 Tigriopus japonicus Species 0.000 description 2
241000607598 Vibrio Species 0.000 description 2
240000008042 Zea mays Species 0.000 description 2
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
235000002017 Zea mays subsp mays Nutrition 0.000 description 2
230000003187 abdominal effect Effects 0.000 description 2
238000005273 aeration Methods 0.000 description 2
125000004103 aminoalkyl group Chemical group 0.000 description 2
230000005875 antibody response Effects 0.000 description 2
230000036528 appetite Effects 0.000 description 2
235000019789 appetite Nutrition 0.000 description 2
238000009360 aquaculture Methods 0.000 description 2
244000144974 aquaculture Species 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
229960005274 benzocaine Drugs 0.000 description 2
230000003115 biocidal effect Effects 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
239000012141 concentrate Substances 0.000 description 2
235000005822 corn Nutrition 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000003795 desorption Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
201000010099 disease Diseases 0.000 description 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
244000078703 ectoparasite Species 0.000 description 2
239000000147 enterotoxin Substances 0.000 description 2
231100000655 enterotoxin Toxicity 0.000 description 2
230000007613 environmental effect Effects 0.000 description 2
210000004392 genitalia Anatomy 0.000 description 2
150000008271 glucosaminides Chemical class 0.000 description 2
229960002751 imiquimod Drugs 0.000 description 2
DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 2
239000002955 immunomodulating agent Substances 0.000 description 2
229940121354 immunomodulator Drugs 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000002757 inflammatory effect Effects 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
239000011859 microparticle Substances 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
150000002772 monosaccharides Chemical class 0.000 description 2
SYXUBXTYGFJFEH-UHFFFAOYSA-N oat triterpenoid saponin Chemical compound CNC1=CC=CC=C1C(=O)OC1C(C=O)(C)CC2C3(C(O3)CC3C4(CCC5C(C)(CO)C(OC6C(C(O)C(OC7C(C(O)C(O)C(CO)O7)O)CO6)OC6C(C(O)C(O)C(CO)O6)O)CCC53C)C)C4(C)CC(O)C2(C)C1 SYXUBXTYGFJFEH-UHFFFAOYSA-N 0.000 description 2
229940046166 oligodeoxynucleotide Drugs 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
229950010550 resiquimod Drugs 0.000 description 2
BXNMTOQRYBFHNZ-UHFFFAOYSA-N resiquimod Chemical compound C1=CC=CC2=C(N(C(COCC)=N3)CC(C)(C)O)C3=C(N)N=C21 BXNMTOQRYBFHNZ-UHFFFAOYSA-N 0.000 description 2
230000004044 response Effects 0.000 description 2
-1 ssociated Species 0.000 description 2
108010004034 stable plasma protein solution Proteins 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
230000004083 survival effect Effects 0.000 description 2
230000009885 systemic effect Effects 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
230000000451 tissue damage Effects 0.000 description 2
231100000827 tissue damage Toxicity 0.000 description 2
239000003053 toxin Substances 0.000 description 2
231100000765 toxin Toxicity 0.000 description 2
108700012359 toxins Proteins 0.000 description 2
239000012646 vaccine adjuvant Substances 0.000 description 2
229940124931 vaccine adjuvant Drugs 0.000 description 2
239000000277 virosome Substances 0.000 description 2
LLXVXPPXELIDGQ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(2,5-dioxopyrrol-1-yl)benzoate Chemical compound C=1C=CC(N2C(C=CC2=O)=O)=CC=1C(=O)ON1C(=O)CCC1=O LLXVXPPXELIDGQ-UHFFFAOYSA-N 0.000 description 1
VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
VHJLVAABSRFDPM-UHFFFAOYSA-N 1,4-dithiothreitol Chemical compound SCC(O)C(O)CS VHJLVAABSRFDPM-UHFFFAOYSA-N 0.000 description 1
HQFLTUZKIRYQSP-UHFFFAOYSA-N 3-ethyl-2h-1,3-benzothiazole-6-sulfonic acid Chemical compound OS(=O)(=O)C1=CC=C2N(CC)CSC2=C1 HQFLTUZKIRYQSP-UHFFFAOYSA-N 0.000 description 1
241000238876 Acari Species 0.000 description 1
ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
241001235715 Caligus belones Species 0.000 description 1
241001325422 Caligus longirostris Species 0.000 description 1
241000283707 Capra Species 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
241000588722 Escherichia Species 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
241000701533 Escherichia virus T4 Species 0.000 description 1
108010040721 Flagellin Proteins 0.000 description 1
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
229920002683 Glycosaminoglycan Polymers 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
238000012313 Kruskal-Wallis test Methods 0.000 description 1
241001235686 Lepeophtheirus pectoralis Species 0.000 description 1
241001382017 Lepeophtheirus thompsoni Species 0.000 description 1
206010062049 Lymphocytic infiltration Diseases 0.000 description 1
241000237852 Mollusca Species 0.000 description 1
208000029549 Muscle injury Diseases 0.000 description 1
241000186359 Mycobacterium Species 0.000 description 1
241000187481 Mycobacterium phlei Species 0.000 description 1
208000030852 Parasitic disease Diseases 0.000 description 1
101710176384 Peptide 1 Proteins 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
241000277289 Salmo salar Species 0.000 description 1
101710172711 Structural protein Proteins 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
238000002835 absorbance Methods 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
230000029936 alkylation Effects 0.000 description 1
238000005804 alkylation reaction Methods 0.000 description 1
239000001099 ammonium carbonate Substances 0.000 description 1
235000012501 ammonium carbonate Nutrition 0.000 description 1
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 1
239000011324 bead Substances 0.000 description 1
210000004369 blood Anatomy 0.000 description 1
239000008280 blood Substances 0.000 description 1
239000001045 blue dye Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
230000005587 bubbling Effects 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000000919 ceramic Substances 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
230000002354 daily effect Effects 0.000 description 1
238000000326 densiometry Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000003628 erosive effect Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
238000010195 expression analysis Methods 0.000 description 1
229960004279 formaldehyde Drugs 0.000 description 1
235000019256 formaldehyde Nutrition 0.000 description 1
239000013505 freshwater Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
239000011521 glass Substances 0.000 description 1
210000002175 goblet cell Anatomy 0.000 description 1
210000003128 head Anatomy 0.000 description 1
238000007825 histological assay Methods 0.000 description 1
230000013632 homeostatic process Effects 0.000 description 1
230000028996 humoral immune response Effects 0.000 description 1
206010020718 hyperplasia Diseases 0.000 description 1
230000036737 immune function Effects 0.000 description 1
230000036039 immunity Effects 0.000 description 1
230000001759 immunoprophylactic effect Effects 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
230000015788 innate immune response Effects 0.000 description 1
230000016507 interphase Effects 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002955 isolation Methods 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
238000001906 matrix-assisted laser desorption--ionisation mass spectrometry Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
229940055036 mycobacterium phlei Drugs 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
230000000426 osmoregulatory effect Effects 0.000 description 1
230000036281 parasite infection Effects 0.000 description 1
244000052769 pathogen Species 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
238000010647 peptide synthesis reaction Methods 0.000 description 1
229940023041 peptide vaccine Drugs 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000012071 phase Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
229920000136 polysorbate Polymers 0.000 description 1
238000009021 pre-vaccination Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
239000000047 product Substances 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000001012 protector Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000003252 repetitive effect Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000007790 scraping Methods 0.000 description 1
210000002955 secretory cell Anatomy 0.000 description 1
238000000926 separation method Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
230000003068 static effect Effects 0.000 description 1
230000000638 stimulation Effects 0.000 description 1
239000000758 substrate Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
230000008719 thickening Effects 0.000 description 1
238000001269 time-of-flight mass spectrometry Methods 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
231100000027 toxicology Toxicity 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000007306 turnover Effects 0.000 description 1
238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
238000005406 washing Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Tropical Medicine & Parasitology (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Toxicology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Wood Science & Technology (AREA)
Mycology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CA2873599A 2012-05-17 2012-05-17 Peptides induisant chez les poissons une reponse immunitaire contre les copepodes et/ou la formation d'un bouclier muqueux, vaccins, utilisations et methodes pour moduler la reponse immunitaire d'un poisson et/ou induire la production d'un bouclier muqueux Abandoned CA2873599A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/IB2012/052487 WO2013171548A2 (fr)	2012-05-17	2012-05-17	Peptides induisant chez les poissons une réponse immunitaire contre les copépodes et/ou la formation d'un bouclier muqueux, vaccins, utilisations et méthodes pour moduler la réponse immunitaire d'un poisson et/ou induire la production d'un bouclier muqueux

Publications (1)

Publication Number	Publication Date
CA2873599A1 true CA2873599A1 (fr)	2013-11-21

Family

ID=49584397

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2873599A Abandoned CA2873599A1 (fr)	2012-05-17	2012-05-17	Peptides induisant chez les poissons une reponse immunitaire contre les copepodes et/ou la formation d'un bouclier muqueux, vaccins, utilisations et methodes pour moduler la reponse immunitaire d'un poisson et/ou induire la production d'un bouclier muqueux

Country Status (5)

Country	Link
AR (1)	AR092320A1 (fr)
CA (1)	CA2873599A1 (fr)
GB (1)	GB2522119A (fr)
NO (1)	NO342822B1 (fr)
WO (1)	WO2013171548A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NO343281B1 (en) *	2016-12-30	2019-01-14	Aqua Health As	Peptides for the inhibition of trypsin and sea lice infestation.
NO343723B1 (en) *	2016-06-10	2019-05-20	Aqua Health As	Peptides for the inhibition of trypsin and sea lice infestation.
NO348323B1 (en) *	2021-11-08	2024-11-18	Kapp Det Gode Haap As	Peptides for the inhibition of parasite infection

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2397553B1 (fr) *	2004-07-28	2016-05-04	National Research Council Of Canada	Vaccins recombinants contre les copépodes caligides (poux du poisson) et séquences d'antigène associées
CU23919B1 (es) *	2010-09-28	2013-07-31	Ct De Ingeniería Genética Y Biotecnología	Composición vacunal para el control de las infestaciones por ectoparásitos

2012
- 2012-05-17 WO PCT/IB2012/052487 patent/WO2013171548A2/fr not_active Ceased
- 2012-05-17 CA CA2873599A patent/CA2873599A1/fr not_active Abandoned
- 2012-05-17 GB GB1421363.1A patent/GB2522119A/en not_active Withdrawn
2013
- 2013-05-16 AR ARP130101697A patent/AR092320A1/es unknown
2014
- 2014-12-12 NO NO20141508A patent/NO342822B1/no unknown

Also Published As

Publication number	Publication date
AR092320A1 (es)	2015-04-15
WO2013171548A2 (fr)	2013-11-21
NO342822B1 (no)	2018-08-13
GB201421363D0 (en)	2015-01-14
GB2522119A (en)	2015-07-15
NO20141508A1 (no)	2015-02-05

Publication	Publication Date	Title
Rahman et al.	2002	The outer membrane fraction of Flavobacterium psychrophilum induces protective immunity in rainbow trout and ayu
JP6874031B2 (ja)	2021-05-19	アイメリアに対する免疫応答を強化するか又はアイメリア感染症を制限する組成物及び方法
Alishahi et al.	2006	Temperature-dependent protection against Ichthyophthirius multifiliis following immunisation of rainbow trout using live theronts
Yan et al.	2013	Vaccination of goats with DNA vaccine encoding Dim-1 induced partial protection against Haemonchus contortus: A preliminary experimental study
Subramanian et al.	2008	Cloning, expression and evaluation of the efficacy of a recombinant Eimeria tenella sporozoite antigen in birds
Newton et al.	1995	Protection against multiply drug-resistant and geographically distant strains of Haemonchus contortus by vaccination with H11, a gut membrane-derived protective antigen
Jang et al.	2014	Efficacy of formalin-killed Pseudomonas anguilliseptica vaccine on immune gene expression and protection in farmed olive flounder, Paralichthys olivaceus
TW201803590A (zh)	2018-02-01	包含免疫刺激性及抗原性多肽的酵母菌疫苗載體以及其使用方法
Hynes et al.	2011	Immune response of Atlantic salmon to recombinant flagellin
Wang et al.	2019	Molecular characterization, phylogenetic analysis and adjuvant effect of channel catfish interleukin-1βs against Streptococcus iniae
CA2873599A1 (fr)	2013-11-21	Peptides induisant chez les poissons une reponse immunitaire contre les copepodes et/ou la formation d'un bouclier muqueux, vaccins, utilisations et methodes pour moduler la reponse immunitaire d'un poisson et/ou induire la production d'un bouclier muqueux
US8207132B2 (en)	2012-06-26	Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof
Hoan et al.	2016	Identification and immunogenicity of microneme protein 2 (EbMIC2) of Eimeria brunetti
JP2018512152A (ja)	2018-05-17	鳥類ワクチン
EP1289545B1 (fr)	2011-01-26	Vaccin synthetique anti-tique
RU2580294C2 (ru)	2016-04-10	Применение расар в качестве молекулярного адъюванта для вакцин
DK202170436A1 (en)	2021-09-22	Sea Lice Vaccines
JP5971625B2 (ja)	2016-08-17	アジュバント、及び水産用ワクチン
Jiang et al.	2024	Interleukin-17B in common carp (Cyprinus carpio L.): Molecular cloning and immune effects as immune adjuvant of Aeromonas veronii formalin-killed vaccine
RU2768134C2 (ru)	2022-03-23	Применение пептида, усиливающего секрецию соматотропного гормона, в качестве адъюванта вакцины
Wang	2001	Biochemical and immunological characterization of the immobilization antigens of Ichthyophthirius multifiliis

Legal Events

Date	Code	Title	Description
2017-05-24	EEER	Examination request	Effective date: 20170516
2019-10-03	FZDE	Dead	Effective date: 20190822